Atlas Trials

PhaRmacOgenetics and Therapeutic Drug Monitoring In SchizophrEnia

Clinical trial NCT05839613 · NOT_YET_RECRUITING

Trial details

NCT number
NCT05839613
Sponsor
Assistance Publique Hopitaux De Marseille
Status
NOT_YET_RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Patients With Schizophrenia
Start date
2023-05-01
Primary completion
2027-05-01
Enrollment
400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.